| Study Type |
Title Study |
Study Description |
| Memory & Cognition Studies |
HOPE: Health Outreach Program for the Elderly |
This longitudinal study increases our understanding of age-related changes in memory and thinking. It also serves as the Center’s main research registry, where participants agree to be contacted regarding other ADC-approved studies. |
| |
ADNI: Alzheimer’s Disease Neuroimaging Initiative |
This international study will determine if brain imaging (through MRI or PET scans), with the collection of blood and other biological specimens, can help predict the onset and monitor the progression of mild cognitive impairment and AD. |
| |
Understanding False Memory
in AD |
This study seeks to better understand why patients with AD and other dementias frequently remember things that never happened. The ultimate goal of this NIA-sponsored study is to provide the basis for ways to reduce false memories in patients with dementia. |
| Caregiving Support & Education Studies |
Care-Plus
New Study |
A caregiver-based study whose aim is to determine whether an educational intervention can reduce behavior problems in patients with AD and improve caregivers’ emotional well-being. The individual with AD is not involved in the study. CARE-Plus is a 5-week group intervention which offers 90-minute weekly sessions on AD, its symptoms, and tips for improving communication and interactions with the family member. It also focuses on family members’ feelings about their own caregiving skills. |
| Genetic Studies |
MIRAGE: Multi-institutional Research in AD Genetic Epidemiology |
This longstanding study evaluates the association between genetic (hereditary) and non-genetic risk factors for AD. The study is currently recruiting people with a diagnosis of probable AD who also have an unaffected sibling who would be willing to participate with them. The study is being conducted at multiple sites in the US and abroad. |
|
| |
REVEAL III: Risk Evaluation and Education for Alzheimer's Disease |
This study is a multi-center, nationwide research project. The goal of REVEAL is to provide healthy adult children and siblings of AD patients with genetic susceptibility testing and information about their own chances to develop the disease. |
| Treatment Studies |
Flurizan II™
New Study |
The Flurizan II™ Study is a continuing multi-national, multi-center study that will evaluate the effectiveness of a new medication, Flurizan, in slowing the progression of AD. The study is looking for participants diagnosed with mild AD who have a caregiver who can accompany them to clinic visits. |
